Global Patent Index - EP 2029129 A1

EP 2029129 A1 20090304 - GESTAGEN COMBINATION AND AN INSULIN SENSITIZER FOR TREATING PCOS

Title (en)

GESTAGEN COMBINATION AND AN INSULIN SENSITIZER FOR TREATING PCOS

Title (de)

KOMBINATION AUS EINEM GESTAGEN UND EINEM INSULINSENSITIZER ZUR BEHANDLUNG VON PCOS

Title (fr)

COMBINAISON D'UN GESTAGÈNE ET D'UN SENSIBILISATEUR À L'INSULINE POUR TRAITER LE PCOS

Publication

EP 2029129 A1 20090304 (DE)

Application

EP 07725596 A 20070526

Priority

  • EP 2007004700 W 20070526
  • DE 102006026026 A 20060601

Abstract (en)

[origin: WO2007137797A1] The invention relates to a medicament which, as an active substance combination, contains at least one contraceptively active gestagen as an individual hormone component and at least one insulin sentitizer. Said medicament is particularly suitable for the prophylaxis of or for the therapy of pathological conditions caused by the polycystic ovary syndrome (PCOS).

IPC 8 full level

A61K 31/155 (2006.01); A61K 31/4439 (2006.01); A61K 31/57 (2006.01); A61P 5/24 (2006.01); A61P 5/28 (2006.01)

CPC (source: EP US)

A61K 31/155 (2013.01 - EP US); A61K 31/4439 (2013.01 - EP US); A61K 31/567 (2013.01 - EP US); A61K 31/57 (2013.01 - EP US); A61K 31/585 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 5/24 (2017.12 - EP); A61P 5/28 (2017.12 - EP); A61P 5/48 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 15/08 (2017.12 - EP); A61P 15/18 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP)

C-Set (source: EP US)

  1. A61K 31/155 + A61K 2300/00
  2. A61K 31/4439 + A61K 2300/00
  3. A61K 31/567 + A61K 2300/00
  4. A61K 31/57 + A61K 2300/00
  5. A61K 31/585 + A61K 2300/00

Citation (search report)

See references of WO 2007137797A1

Citation (examination)

  • GOLDENSTEIN S ET AL: "Polycystic ovaries - The PCO syndrome", MEDIZINISCHE MONATSSCHRIFT FUER PHARMAZEUTEN, STUTTGART, DE, vol. 25, no. 7, 1 January 2002 (2002-01-01), pages 233 - 235, XP009103090, ISSN: 0342-9601
  • SEBASTÍAN CARRANZA-LIRA ET AL: "The relation of the gonadotrophin response to chlormadinone according to body weight in patients with amenorrhea due to polycystic ovarian syndrome", EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, vol. 66, no. 2, 1 June 1996 (1996-06-01), pages 161 - 164, XP055081521, ISSN: 0301-2115, DOI: 10.1016/0301-2115(96)02398-6
  • DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; June 2002 (2002-06-01), CARRANZA-LIRA SEBASTIÁN ET AL: "[Ultrasonographic and lipid changes in polycystic ovary syndrome according to the type of treatment ].", XP002723822, Database accession no. NLM12148471 & GINECOLOGÍA Y OBSTETRICIA DE MÉXICO JUN 2002, vol. 70, June 2002 (2002-06-01), pages 285 - 288, ISSN: 0300-9041
  • EMIG R ET AL: "Therapie des Syndroms der polyzystichen Ovarien // Treatment of polycystic ovary syndrome", TAEGLICHE PRAXIS, XX, MUENCHEN, DE, vol. 47, no. 1, 7 March 2006 (2006-03-07), pages 59 - 68, XP009089164, ISSN: 0494-464X

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA HR MK RS

DOCDB simple family (publication)

DE 102006026026 A1 20071206; EP 2029129 A1 20090304; EP 2749278 A1 20140702; US 2009118245 A1 20090507; US 8097604 B2 20120117; WO 2007137797 A1 20071206

DOCDB simple family (application)

DE 102006026026 A 20060601; EP 07725596 A 20070526; EP 14000779 A 20070526; EP 2007004700 W 20070526; US 32552908 A 20081201